A new piece by Bill of Health contributor Art Caplan in Forbes: Nathan Nascimento thinks that right-to-try laws aimed at the terminally ill are sound public policy. He is wrong. Mr. Nascimento’s commentary misrepresents the complexities of the drug development process … Continue reading
Source: Bill of Health, examining the intersection of law and health care, biotech & bioethics.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.